Lv3
248 积分 2023-09-15 加入
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
1天前
已完结
HDAC inhibitor GCJ-490A modulates tumor microenvironment and synergizes with PD-1 antibody against breast and lung cancers in syngeneic murine models
1个月前
已完结
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
1个月前
已完结
The next generation of immunotherapies for lung cancers
1个月前
已完结
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
1个月前
已完结
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
1个月前
已完结
Harnessing cytokines and chemokines for cancer therapy
1个月前
已完结
TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
1个月前
已完结
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling
1个月前
已完结
Activation of epigenetic reprogramming via crotonylation overcomes resistance to EGFR-TKI therapy in lung cancer
3个月前
已完结
皖公网安备34019202002308
